Patients with type 2 diabetes may find that incretin mimetics may help them to better manage their blood glucose levels. The U.S. Food and Drug Administration (FDA) approved one of these medications, Byetta, in April 2005, but now the drug may potentially be linked to pancreatic cancer, pancreatitis, thyroid cancer and other complications. You may be entitled to file an Alabama Byetta lawsuit to seek compensation for your injuries if you took the medication and later suffered from adverse effects.
Byetta helps to stimulate the pancreas in an effort to produce more insulin in type 2 diabetes patients. As the patient’s body produces higher levels of insulin, he or she is better able to control his or her blood sugar levels.
However, and although Byetta’s manufacturer, Amylin Pharmaceuticals, maintains that the drug is safe and causes little or no side effects, plaintiffs filing lawsuits against the company allege that Amylin used unethical marketing tactics in an effort to increase sales of the product. In fact, between 2005 and 2008, Byetta allegedly grossed over $700 for the manufacturer.
Those who have allegedly been injured may be entitled to file Alabama Byetta lawsuits to seek compensation for their injuries if they have taken the drug and subsequently developed adverse or life-threatening complications. If you feel you have a claim, an experienced attorney can help you with your case.
Plaintiffs Allege Side Effects
Byetta users may be six times more likely to develop pancreatic cancer, according to data obtained from clinical trials and adverse event reports submitted to the FDA. Byetta users may also be twice as likely to undergo hospitalization due to pancreatitis as those who took other drugs for type 2 diabetes, according to a study published in February 2013.
If you or someone you love have experienced one or more of the following adverse side effects while taking Byetta, you may be entitled to file an Alabama Byetta lawsuit and seek compensation for injuries. Damages may include pain and suffering, lost wages, loss of income and medical expenses.
- Allergic reactions
- Kidney damage
- Renal impairment
- Chest pain
Lawsuits surrounding incretin mimetics such as Byetta, Janumet, Januvia and Victoza have recently been consolidated in the U.S. District Court, Southern District of California into a multidistrict litigation (MDL). Plaintiffs are alleging that the medications caused adverse and sometimes life-threatening health complications, according to court documents.
As of September 11, 2013, roughly 60 claims were filed in the court. However, court documents indicate that by October 17, 2013, that number more than doubled to reach 150 separate cases from plaintiffs alleging injuries and fatalities due to the medications. Five bellwether trials have been scheduled in the proceeding, three of which will take place in 2014 and two of which will take place in 2015.
Attorneys speculate that the increasing number of claims may be attributed to the ever-growing interest and concern surrounding this class of medications. More plaintiffs may continue to move forward in an attempt to seek compensation from the manufacturers for their injuries, although specific damages will depend on each individual’s situation and alleged injury.
Injured? We Can Help You to File Your Alabama Byetta Lawsuit
Are you or someone you love suffering from renal impairment, pancreatic cancer or thyroid cancer and you received the diagnosis while using Byetta? At Attorney Group for Alabama, we can review your case, free of charge, and answer your questions pertaining to Alabama Byetta lawsuits. We will help you to determine if you have a valid claim and connect you with experienced attorneys who will handle your Alabama Byetta lawsuit to help you seek the compensation to which you may be entitled.